CCK2 receptor antagonists: Pharmacological tools to study the gastrin-ECL cell-parietal cell axis

Regulatory Peptides

Volumn 80, Issue 1-2, 1999, Pages 1-12

  Håkanson, Rolf ^a   Ding, Xi Qin ^a   Norlén, Per ^a   Lindström, Erik ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

CCK2 receptor antagonists; ECL cells; Endocrine cells; Gastric acid secretion; Histamine; Histidine decarboxylase; Oxyntic mucosa; Paracrine cells; Serum gastrin

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 1 [2,3 DIHYDRO 1 (2' METHYLPHENACYL) 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; 1 [2,3 DIHYDRO 2 OXO 1 PIVALOYLMETHYL 5 (2 PYRIDYL) 1H 1,4 BENZODIAZEPIN 3 YL] 3 [3 (METHYLAMINO)PHENYL]UREA; 1 [5 (3 AZABICYCLO[3.2.2]NON 3 YL) 2,3 DIHYDRO 1 METHYL 2 OXO 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; 4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; 5 [[[[(3,5 DICARBOXYPHENYL)AMINO]CARBONYL] 2 PHENYLETHYLAMINO]CARBONYL] 6 [[(1 ADAMANTYLMETHYL)AMINO]CARBONYL]INDOLE; AG 041R; ALPHA FLUOROMETHYLHISTIDINE; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CHROMOGRANIN A; GASTRIN RECEPTOR; HISTAMINE; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTIDINE DECARBOXYLASE; OMEPRAZOLE; PANCREASTATIN; PD 135158; RP 73870; UNCLASSIFIED DRUG; AG-041R; BENZODIAZEPINE DERIVATIVE; CARBANILAMIDE DERIVATIVE; CHOLECYSTOKININ B RECEPTOR; GASTRIN; HORMONE ANTAGONIST; INDOLE DERIVATIVE; PANCREAS HORMONE;

DOG; ENTEROCHROMAFFIN CELL; ENZYME ACTIVITY; GASTRIN RELEASE; HISTAMINE RELEASE; HYPERGASTRINEMIA; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; RECEPTOR AFFINITY; RECEPTOR BLOCKING; REVIEW; STOMACH ACID SECRETION; STOMACH PARIETAL CELL; ANIMAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METABOLISM; SECRETION; STOMACH; STOMACH ACID;

ANIMALS; BENZODIAZEPINES; BENZODIAZEPINONES; GASTRIC ACID; GASTRINS; HISTAMINE; HISTIDINE DECARBOXYLASE; HORMONE ANTAGONISTS; HUMANS; INDOLES; PANCREATIC HORMONES; PARIETAL CELLS, GASTRIC; PHENYLUREA COMPOUNDS; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; STOMACH;

EID: 0032587636     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(99)00008-7     Document Type: Review

References (117)

1. Håkanson R, Larsson L-I, Liedberg G, Oscarson J, Sundler F, Vang J. Effects of antrectomy or porta-caval shunting on the histamine-storing endocrine-like cells in oxyntic mucosa of rat stomach. A fluorescence histochemical, electron microscopic and chemical study. J Physiol 1976;259:785-800.
2. Håkanson R, Böttcher G, Ekblad E, Panula P, Simonsson M, Dohlsten M, Hallberg T, Sundler F. Histamine in endocrine cells in the stomach. A survey of several species using a panel of histamine antibodies. Histochemistry 1986;86:5-17.
3. Håkanson R, Tielemans Y, Chen D, Andersson K, Ryberg B, Mattsson H, Sundler F. The biology and pathobiology of the ECL cells. Yale J Biol Med 1992;65:761-74.
4. Håkanson R, Chen D, Sundler F. The ECL cells. In: Johnson LR, editor. Physiology of the gastrointestinal tract. New York: Raven Press, 1994:1171-1184.
5. Håkanson R, Chen D, Andersson K, Monstein H-J, Zhao C-M, Ryberg B, Sundler F. The biology and physiology of the ECL cell. Yale J Biol Med 1994;65:761-7.
6. Nissinen M, Panula P. Histamine-storing cells in the oxyntic mucosa of the rat stomach: a transmission electron microscopic study employing fixation with carbodiimide. J Histochem Cytochem 1993;41:1405-12.
7. Håkanson R, Böttcher G, Sundler F, Vallgren S. Activation and hyperplasia of gastrin and enterochromaffin-like cells in the stomach. Digestion 1986;35(Suppl):23-41.
8. Håkanson R, Owman C, Sporrong B, Sundler F. Electron microscopic identification of the histamine-storing argyrophil enterochromaffin-like cells in the rat stomach. Z Zellforsch 1971;122:460-8.
9. Böttcher G, Håkanson R, Nilsson G, Seensalu R, Sundler F. Effects of long-term hypergastrinaemia on the ultrastructure of enterochromaffin-like cells in the stomach of the rat, hamster and guinea pig. Cell Tissue Res 1989;256:247-57.
10. Chen D, Zhao C-M, Nylander A-G, Håkanson R. Time course of hypertrophic and ultrastructural responses of rat stomach enterochromaffin-like cells to sustained hypergastrinemia. Cell Tissue Res 1996;284:55-63.
11. Håkanson R, Ding X-Q, Norlén P, Chen D. Circulating pancreastatin is a marker for the enterochromaffin-like cells of the rat stomach. Gastroenterology 1995;108:1445-52.
12. Kimura K, Chen D, Lindström E, Zhao CM, Håkanson R. Evidence that rat stomach ECL cells represent the main source of circulating pancreastatin. Regul Pept 1997;68:177-80.
13. 14 in rat stomach ECL cells. Regul Pept 1997;70:121-33.
14. Ding X-Q, Chen D, Håkanson R. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase. Gastroenterology 1995;109:1181-7.
15. Ding X-Q, Lindström E, Håkanson R. Cholecystokinin-B/gastrin receptor blockade suppresses the activity of rat stomach ECL cells. Pharmacol Toxicol 1997;81:19-25.
16. Ding X-Q, Lindström E, Håkanson R. Evaluation of three novel cholecystokinin-B/gastrin receptor antagonists: a study of their effects on rat stomach ECL cell activity. Pharmacol Toxicol 1997;81:232-7.
17. Ding X-Q, Lindström E, Håkanson R. Time-course of deactivation of rat stomach ECL cells following cholecystokinin-B/gastrin receptor blockade. Br J Pharmacol 1997;122:1-6.
18. Ding X-Q, Kitano M, Håkanson R. Sustained cholecystokinin-B/gastrin receptor blockade does not impair basal and histamine-stimulated acid secretion in chronic gastric fistula rats. Pharmacol Toxicol 1998;82:177-82.
19. Ding X-Q, Håkanson R. Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo. Pharmacol Toxicol 1996;79:124-30.
20. Ding X-Q, Håkanson R. Effect of cholecystokinin-B/gastrin receptor blockade on gastric acid secretion in conscious rats. Pharmacol Toxicol 1996;79:324-30.
21. Lindström E, Björkqvist M, Håkanson R. Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells. Br J Pharmacol 1999;in press.
22. Norlén P, Lindström E, Ding X-Q, Kitano M, Håkanson R. Reversibility of cholecystokinin-B/gastrin receptor blockade. A study of the gastrin-ECL cell axis in the rat. Pharmacol Toxicol 1999;in press.
23. Chen D, Monstein H-J, Nylander A-G, Zhao C-M, Sundler F, Håkanson R. Acute responses of rat stomach enterochromaffin-like cells to gastrin: secretory activation and adaptation. Gastroenterology 1994;107:18-27.
24. Lindström E, Björkqvist M, Boketoft Å, Chen D, Zhao C-M, Kimura K, Håkanson R. Neurohormonal regulation of histamine and pancreastatin secretion from isolated rat stomach ECL cells. Regul Pept 1997;71:73-86.
25. Håkanson R, Tielemans Y, Chen D, Andersson K, Mattsson H, Sundler F. Time-dependent changes in enterochromaffin-like cell kinetics in stomach of hypergastrinemic rats. Gastroenterology 1993;105:15-21.
26. Håkanson R, Sundler F. Proposed mechanism of gastric carcinoids. The gastrin hypothesis. Eur J Clin Invest 1990;20(Suppl 1):65-71.
27. Dial E, Thompson WJ, Rosenfeld GC. Isolated parietal cells: histamine response and pharmacology. J Pharmacol Exp Ther 1981;219:585-90.
28. + production of isolated parietal cells in response to glucagon and histamine. Eur J Pharmacol 1984;98:9-18.
29. Cabero JL, Li Z-Q, Mårdh S. Gastrin potentiates histamine-stimulated aminopyrine accumulation in isolated rat parietal cells. Am J Physiol 1991;261:G621-627.
30. Li Z-Q, Cabero JL, Nilsson BO, Mårdh S. Direct gastrin action on isolated rat parietal cells induces morphological transformation. Biochim Biophys Acta 1993;1175:250-6.
31. Black JW, Shankley NP. How does gastrin act to stimulate oxyntic cell secretion?. Trends Pharmacol Sci 1987;8:486-90.
32. Håkanson R, Sundler F. Do histamine-storing cells in the gastric mucosa mediate the acid-stimulating action of gastrin? In: Uvnäs B, editor. Histamine and histamine antagonists handbook of experimental pharmacology, vol. 97. Berlin: Springer Verlag, 1991:325-346.
33. Waldum HL, Sandvik AK, Brenna E, Petersen H. The gastrin-histamine sequence in the regulation of gastric acid secretion. Gut 1991;32:698-700.
34. 2 receptor antagonists. Gastroenterology 1993;105:963-8.
35. Andersson K, Cabero JL, Mattsson H, Håkanson R. Gastric acid secretion after depletion of enterochromaffin-like cell histamine. Scand J Gastroenterol 1996;31:24-30.
36. Sandvik AK, Waldum HL, Kleveland PM, Schultze-Søgnen B. Gastrin produces an immediate and dose-dependent histamine release preceding acid secretion in the totally isolated, vascularly perfused rat stomach. Scand J Gastroenterol 1987;22:803-8.
37. Rangachari PK. Histamine release by gastric stimulants. Nature 1975;253:53-5.
38. Ekblad EBM. Histamine, the sole mediator of pentagastrin-stimulated acid secretion. Acta Physiol Scand 1985;125:135-43.
39. Bergqvist E, Öbrink KJ. Gastrin-histamine as a normal sequence in gastric acid stimulation in the rabbit. Ups J Med Sci 1979;84:145-54.
40. Brenna E, Waldum HL. Studies of isolated parietal and enterochromaffin-like cells from the rat. Scand J Gastroenterol 1991;26:1295-306.
41. Prinz C, Kajimura M, Scott DR, Mercier F, Helander HF, Sachs G. Histamine secretion from rat enterochromaffin-like cells. Gastroenterology 1993;105:449-61.
42. Aures D, Davidson WD, Håkanson R. Histidine decarboxylase in gastric mucosa of various mammals. Eur J Pharmacol 1969;8:100-7.
43. Bergmark J, Granerus G, Henningsson S, Lundell L, Rosengren E. Histamine metabolism of guinea-pig gastric mucosa. J Physiol 1976;257:419-31.
44. Kubota H, Taguchi Y, Tohyama M, Matsuura N, Shiosaka S, Ishihara T, Watanabe T, Shiotani Y, Wada H. Electron microscopic identification of histidine decarboxylase-containing endocrine cells of the rat gastric mucosa. An immunohistochemical analysis. Gastroenterology 1984;84:496-502.
45. Höcker M, Zhang Z-S, Fenstermacher DA, Tågerud S, Chulak M, Joseph D, Wang TC. Rat histidine decarboxylase promoter is regulated by gastrin through a protein kinase C pathway. Am J Physiol 1996;270:G619-633.
46. Håkanson R, Kroesen JH, Liedberg G, Oscarson J, Rehfeld JF, Stadil F. Correlation between serum gastrin concentration and rat stomach histidine decarboxylase activity. J Physiol 1974;234:483-98.
47. Prinz C, Scott DR, Hurwitz D, Helander HF, Sachs G. Gastrin effects on isolated rat enterochromaffin-like cells in primary culture. Am J Physiol 1994;267:G663-72.
48. Dimaline R, Sandvik AK. Histidine decarboxylase gene expression in rat fundus is regulated by gastrin. FEBS Lett 1991;28:20-2.
49. Sandvik AK, Dimaline R, Mårvik R, Brenna E, Waldum HL. Gastrin regulates histidine decarboxylase activity and mRNA abundance in rat oxyntic mucosa. Am J Physiol 1994;267:G254-255.
50. Håkanson R, Oscarson J, Sundler F. Gastrin and trophic control of the oxyntic mucosa. Scand J Gastroenterol 1986;21(Suppl):18-30.
51. 3H-thymidine incorporation in the oxyntic mucosa from rat and dog. Digestion 1988;39:91-9.
52. Tielemans Y, Håkanson R, Sundler F, Willems G. Proliferation of enterochromaffin-like cells in omeprazole-treated hypergastrinemic rats. Gastroenterology 1989;96:723-9.
53. Tielemans Y, Axelson J, Sundler F, Willems G, Håkanson R. Serum gastrin concentration affects the self replication rate of the enterochromaffin-like cells in the rat stomach. Gut 1990;31:274-8.
54. Innis RB, Snyder SH. Distinct cholecystokinin receptors in brain and pancreas. Proc Natl Acad Sci USA 1980;77:6917-28.
55. Beinfeld MC. Cholecystokinin in the central nervous system: a mini review. Neuropeptides 1983;3:411-27.
56. Kopin AS, Lee Y-M, McBride EW, Miller LJ, Lu M, Lin HY, Kolakowski LF, Beinborn M. Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci USA 1992;89:3605-9.
57. Wank SA, Harkins R, Jensen RT, Shapira H, de Weerth A, Slattery T. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci USA 1992;89:3125-9.
58. Wank SA, Pisegna JR, de Weerth A. Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc Natl Acad Sci USA 1992;89:8691-5.
59. Silvente-Poirot S, Dufresne M, Vayasse N, Fourmy D. The peripheral cholecystokinin receptors. Eur J Biochem 1993;215:513-29.
60. Hill DR, Campbell NJ, Shaw TM, Woodruff GN. Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective non-peptide CCK antagonists. J Neurosci 1987;7:2967-76.
61. Hill DR, Shaw TM, Woodruff GN. Species differences in the localization of 'peripheral' type CCK receptors in rodent brain. Neurosci Lett 1987;79:286-98.
62. Pisegna JR, Weerth AD, Huppi K, Wank SA. Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization. Biochem Biophys Res Commun 1992;189:296-303.
63. Chiba T, Kinoshita Y, Morishita T, Nakata H, Nakamura A, Hosoda S. Receptors for gastrin on gastric carcinoid tumor membranes of Mastomys natalensis. Biochem Biophys Res Commun 1991;177:739-44.
64. Roche S, Gusdinar T, Bali J-P, Magous R. 'Gastrin' and 'CCK' receptors on histamine- and somatostatin-containing cells from rabbit fundic mucosa. I. Characterization by means of agonists . Biochem Pharmacol 1991;42:765-70.
65. Asahara M, Kinoshita Y, Nakata H, Matsushima Y, Naribayashi Y, Nakamura A, Matsui H, Chihara K, Yamamoto J, Ichikawa A, Chiba T. Gastrin receptor genes are expressed in gastric parietal and enterochromaffin-like cells of Mastomys natalensis. Dig Dis Sci 1994;39:2149-56.
66. Chang RSL, Lotti VJ. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. Proc Natl Acad Sci USA 1986;83:4923-6.
67. 3H] L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand. Mol Pharmacol 1989;35:803-10.
68. Lotti VJ, Chang RSL. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Eur J Pharmacol 1989;162:273-80.
69. Sandvik AK, Waldum HL. CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion. Am J Physiol 1991;260:G925-928.
70. Patel S, Smith AJ, Chapman KL, Fletcher AE, Kemp JA, Marshall GR, Hargreaves RJ, Ryecroft W, Iversen LL, Iversen SD, Baker R, Showell GA, Bourrain S, Neduvelil JG, Matassa VG, Freedman SB. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo. Mol Pharmacol 1994;46:943-8.
71. Nishida A, Miyata K, Tsutsumi R, Yuki H, Akuzawa S, Kobayashi A, Kamato T, Ito H, Yamano M, Katuyama Y, Satoh M, Ohta M, Honda K. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2′-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl] 3(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vivo and in vitro. J Pharmacol Exp Ther 1994;269:725-31.
72. Takinami Y, Yuki H, Nishida A, Akuzawa S, Uchida A, Takemoto Y, Ohta M, Satoh M, Semple G, Miyata K. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo. Aliment Pharmacol Ther 1997;11:113-20.
73. Nishida A, Kobayashi-Uchida A, Akuzawa S, Takinami Y, Shishido T, Kamato T, Ito H, Yamano M, Yuki H, Nagakura Y, Honda K, Miyata K. Gastrin receptor antagonist YM022 prevents hypersecretion after long term acid suppression. Am J Physiol 1995;269:G699-705.
74. Yuki H, Nishida A, Miyake A, Ito H, Akuzawa S, Takinami Y, Takemoto Y, Miyata K. YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain Pouch Dogs. Dig Dis Sci 1997;42:707-14.
75. Bertrand P, Bohme GA, Durieux C, Guyon C, Capet M, Jeantaud B, Boudeau P, Ducos B, Pendley CE, Martin GE. Pharmacological properties of ureido-acetamides, new potent and selective nonpeptide CCK/gastrin receptor antagonists. Eur J Pharmacol 1994;262:233-45.
76. Pendley CE, Fitzpatrick LR, Capolino AJ, Davis MA, Esterline NJ, Jakubowska A, Bertrand P, Guyon C, Dubroeucq M-C, Martin GE. RP73870, a gastrin/cholecystokinin-B receptor antagonist with potent anti-ulcer activity in the rat. J Pharmacol Exp Ther 1995;273:1015-22.
77. Kalindjian SB, Buck IM, Davis JMR, Dunstone DJ, Hudson ML, Low CMR, McDonald IM, Pether MJ, Steel KIM, Tozer MJ, Vinter JG. Non-peptide cholecystokinin-B/gastrin receptor antagonists based on bicyclic, heteroaromatic skeletons. J Med Chem 1996;39:1806-15.
78. Hills DM, Gerskowitch P, Roberts SP, Welsh NJ, Shankley NP, Black JW. Pharmacological analysis of the CCK-B/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat. Br J Pharmacol 1996;119:1401-10.
79. Baba A, Hoshino E, Onoma M, Esaki T, Takeda K. Pharmacological profile of AG041R. A novel selective gastrin/CCK-B antagonist (abstract). Gastroenterology 1995;108:A950.
80. Kinoshita Y, Nakata H, Asahara M, Kawanami C, Matsushima Y, Kishi K, Hoshino E, Baba A, Chiba T. Effect of a new gastrin/CCK-B receptor antagonist AG-041R on ECL carcinoid tumor cells of Mastomys natalensis (abstract). Regul Pept 1996;64:90.
81. Hughes J, Boden P, Costall B, Domeney A, Kelly E, Horwell DC, Hunter JC, Pinnock RD, Woodruff GN. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci 1990;87:6728-32.
82. Horwell DC. Development of CCK-B antagonists. Neuropeptides 1991;19(Suppl):57-64.
83. Boden PR, Higginbottom M, Hill DK, Horwell DC, Hughes J, Rees DC, Robert E, Singh L, Suman-Chauhan N, Woodruff GN. Cholecystokinin dipeptoid antagonists: design, synthesis and anxiolytic profile of some novel CCK-A and CCK-B selective and 'mixed' CCK-A/CCK-B antagonists. J Med Chem 1993;36:552-65.
84. Höcker M, Hughes J, Fölsch UR, Schmidt WE. PD 135158, a CCK-B/gastrin receptor antagonist stimulates rat pancreatic enzyme secretion as a CCK-A receptor agonist. Eur J Pharmacol 1993;242:105-8.
85. Blevins Jr GT, van de Westerlo EMA, Yule OI, Williams JA. Characterization of cholecystokinin-A receptor agonist activity by a family of cholecystokinin-B receptor antagonists. J Pharmacol Exp Ther 1994;269:911-6.
86. Hayward NJ, Harding M, Lloyd SAC, McKnight AT, Hughes J, Woodruff GN. The effect of CCK-B/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat. Br J Pharmacol 1991;104:973-7.
87. Eissele R, Koop H, Bothe-Sandfort E, Arnold R. Gastrin receptor antagonists suppress pentagastrin (PG)-stimulated gastric acid secretion in rats. Gastroenterology 1991;100:A638.
88. Eissele R, Patberg H, Koop H, Krack W, Lorenz W, McKnight AT, Arnold R. Effect of gastrin receptor blockade on endocrine cells in rats during achlorhydria. Gastroenterology 1992;103:1596-601.
89. Schmassmann A, Garner A, Flogerzi B, Hasan MY, Sanner M, Varga L, Halter F. Cholecystokinin type B receptor antagonist PD136,450 is a partial agonist in the stomach and a full agonist in the pancreas of the rat. Gut 1994;35:270-4.
90. Larsson H, Carlsson E, Mattsson H, Lundell L, Sundler F, Sundell G, Wallmark B, Watanabe T, Håkanson R. Plasma gastrin and gastric enterochromaffin-like cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1986;90:391-9.
91. Ryberg B, Mattsson H, Larsson H, Carlsson E. Correlation between inhibition of gastric acid secretion, plasma gastrin and oxyntic mucosal histidine decarboxylase activity in the rat. Scand J Gastroenterol 1989;24:287-92.
92. Curry WJ, Johnston CF, Shaw C, Buchanan KD. Distribution and partial characterization of immunoreactivity to the putative C-terminus of rat pancreastatin. Regul Pept 1990;30:207-19.
93. Curry WJ, Johnson CF, Hutton JC, Arden SD, Rutherford NG, Shaw C, Buchanan KD. The tissue distribution of rat chromogranin-A derived peptides: evidence for differential tissue processing from sequence specific antisera. Histology 1991;96:531-8.
94. Watkinson A, Dockray GJ. Functional control of chromogranin A and B concentrations in the body of the rat stomach. Regul Pept 1992;40:51-61.
95. Andersson K, Chen D, Håkanson R, Mattsson H, Sundler F. Enterochromaffin-like cells in rat stomach: effects of α-fluoromethylhistidine-evoked histamine depletion. A chemical, histochemical and electron-microscopic study. Cell Tissue Res 1992;270:7-13.
96. Andersson K, Håkanson R, Mattsson H, Ryberg B, Sundler F. Hyperplasia of histamine-depleted enterochromaffin-like cells in rat stomach using omeprazole and α-fluoromethylhistidine. Gastroenterology 1992;103:897-904.
97. Song M, Wong H, Ohning G, Walsh JH. Immunohistochemical localization of the gastrin/CCK-B receptor in the rat stomach. Gastroenterology 1996;110:A1120.
98. Larsson H, Carlsson E, Håkanson R, Mattsson H, Nilsson G, Seensalu R, Wallmark B, Sundler F. Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1988;95:1477-86.
99. Tielemans Y, Chen D, Sundler F, Håkanson R, Willems G. Reversibility of the cell kinetic changes induced by omeprazole in the rat oxyntic mucosa. An autoradiographic study using tritiated thymidine. Scand J Gastroenterol 1992;27:155-60.
100. 2+ and elevation of inositol triphosphate by secretagogues in parietal and chief cells isolated from rabbit gastric mucosa. Biochim Biophys Acta 1986;888:116-25.
101. Chiba T, Fisher SK, Park J, Seguin EB, Agranoff BW, Yamada T. Carbamoylcholine and gastrin induce inositol lipid turnover in canine gastric parietal cells. Am J Physiol 1988;255:G99-G105.
102. 3, phorbol esters and exogenous diacyl-glycerol. FEBS Lett 1988;232:83-90.
103. 2+ in individual, acid-secreting rat parietal cells. Biochem Biophys Res Commun 1992;183:1097-102.
104. i by secretagogue stimulation of canine gastric parietal cells. Am J Physiol 1992;262:G420-6.
105. Li Z-Q, Cabero JL, Mårdh S. Gastrin and carbachol require cAMP to elicit aminopyrine accumulation in isolated pig and rat parietal cells. Am J Physiol 1995;268:G82-9.
106. 2+ evaluation in rabbit parietal cells: a novel method to screen gastrin receptor antagonists. Eur J Pharmacol 1996;306:325-33.
107. Nakamura M, Oda M, Kaneko K, Yonei Y, Tsukada N, Komatsu H, Tsugu M, Tsuchiya M. Autoradiographic demonstration of gastrin binding sites in rat gastric mucosa. Peptides 1987;8:391-8.
108. Tarasova NI, Romanov VI, Da Silva PP, Michejda CJ. Numerous cell targets for gastrin in the guinea pig stomach revealed by gastrin/CCK B receptor localization. Cell Tissue Res 1996;283:1-6.
109. Praissman M, Brand DL, Praissman LA, Walden M, Fay ME, Lane BP, Manonkian A, Lu Y-M. Autoradiographic identification of a gastrin receptor on the human parietal cell. Regul Pept 1998;73:183-90.
110. Code CF. Histamine and gastric secretion. In: Wolstenholme G, O'Connor CM, editors. CIBA foundation symposium on histamine. London: Churchill, 1956:189-219.
111. Code CF. Histamine and acid secretion: a later look. Fed Proc 1965;24:1311-21.
112. Kahlson G, Rosengren E, Svahn D, Thunberg R. Mobilization and formation of histamine in the gastric mucosa as related to acid secretion. J Physiol 1964;174:400-16.
113. Aurang K, Spraggs CF, Jordan C, Lloyd KCK. Role of gastrin/CCK-B receptors in meal-stimulated acid secretion in rats. Am J Physiol 1997;272:G1243-8.
114. Gerber JG, Payne NA. The role of gastric secretagogues in regulating gastric histamine release in vitro. Gastroenterology 1992;102:403-8.
115. Payne NA, Gerber JG. Differential effects of somatostatin and prostaglandins on gastric histamine release to pentagastrin. J Pharmacol Exp Ther 1992;263:520-6.
116. Soil AH, Toomey M, Culp D, Shanahan F, Beaven MA. Modulation of histamine release from canine fundic mucosal mast cells. Am J Physiol 1988;254:G40-48.
117. B/gastrin receptor antagonists: recent advances and potential uses in gastric secretory disorders. Yale J Biol Med 1996;69:245-59.